The role of the Research Officer/ Assistant will play a major role in focussing on the critical problem of improving the efficiency of iT cell production, by identifying and unlocking potential differentiation ” bottle necks”, inducing specific T cell lineages and increasing anti-cancer functionality. The outcomes will be of major significance for the Company.
This year has been an exciting and productive one for Cartherics. We opened our new and impressive research and development facility in Notting Hill and we are busy completing the preclinical studies for our lead iNK product for treating ovarian cancer. The follow-on product pipeline is revving up with new CAR target candidates, additional gene […]
Cartherics’ mission is the development of novel, “off-the-shelf” (allogeneic) immune cell therapy products for the treatment of cancer.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
